Relapsed/Refractory Systemic Light Chain Amyloidosis research hub

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

This study is testing a new medicine called linvoseltamab for people with a rare condition called AL amyloidosis. We want to see if it's safe and if it can help people whose condition has come back or who haven't responded to other treatments.